MARÍA PILAR
GARCÍA ALFONSO
Profesora asociada de Ciencias de la Salud
Sheba Medical Center
Ramat Gan, IsraelSheba Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2018
-
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
The Lancet, Vol. 392, Núm. 10142, pp. 123-133